Diagnostics News and Research

RSS

Genome sequence data indicates that common species of malaria may evolve to become bigger threat

Provocative new research shows that the Plasmodium vivax parasite, responsible for nearly 20 million cases of malaria in 2010, may be "rapidly evolving" to overcome the natural resistance conferred by a blood type found in millions of Africans, scientists reported today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

16 Nov 2013

Collaborative initiative set up to create precision medicine treatment pathways for advanced cancers

The Joint Center for Cancer Precision Medicine, a collaborative initiative among Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston Children's Hospital, and the Broad Institute of MIT and Harvard, has been established to create "precision medicine treatment pathways" for patients with advanced cancers and to speed the development of personalized therapies.

16 Nov 2013

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

OPKO Health, Inc., has completed patient recruitment in the first phase 3 trial of Rayaldy to treat patients with secondary hyperparathyroidism, stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

16 Nov 2013

Pancreatic Cancer Action Network teams up with Royal Pains cast to educate on pancreatic cancer

The Pancreatic Cancer Action Network has teamed up with the cast of the USA Network primetime show "Royal Pains" to educate fans and the general public about the severity of pancreatic cancer. Mark Feuerstein, who plays Dr. Hank Lawson, the talented and respected doctor behind a Hamptons medical practice, appears in a new public service announcement for the organization with co-stars Paulo Costanzo, Reshma Shetty, Brooke D'Orsay, and Ben Shenkman.

16 Nov 2013

New Malaria Vaccine Technology Roadmap aims to identify second generation malaria vaccines

The world should aim to have vaccines which reduce malaria cases by 75%, and are capable of eliminating malaria, licensed by 2030, according to the updated 2013 "Malaria Vaccine Technology Roadmap", launched today.

15 Nov 2013

Identifying 'sensome' of microglia could improve treatments for neurodegenerative disorders

Massachusetts General Hospital investigators have used a new sequencing method to identify a group of genes used by the brain's immune cells - called microglia - to sense pathogenic organisms, toxins or damaged cells that require their response.

15 Nov 2013

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

The European Union has funded a 4 year project called TAILORED-Treatment with € 6.000.000,-. The main goal of TAILORED -Treatment is to establish a strategy that can be used to increase the effectiveness of antibiotic treatment, reduce any potential side-effects of therapy, and help limit the emergence of antimicrobial resistance in hospitalized children and adults. The project will be coordinated by Erasmus MC, Rotterdam, the Netherlands.

14 Nov 2013

High-power blue laser gadgets can cause serious eye damage

A type of high-power blue laser toy readily available over the Internet and increasingly popular among male teens and young adults can cause serious, sometimes irreversible, eye damage, according to a report by investigators from Saudi Arabia’s King Khaled Eye Specialist Hospital and Johns Hopkins Medicine.

14 Nov 2013

AMP 2013: EKF Molecular Diagnostics to launch four new PointMan DNA enrichment kits

EKF Diagnostics, the global diagnostics business, announces that EKF Molecular Diagnostics will launch four new PointMan DNA enrichment kits.

From EKF Diagnostics 13 Nov 2013

immatics, Roche enter into cancer vaccine and immunotherapy deal

immatics biotechnologies GmbH and Roche today announced a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics.

13 Nov 2013

International research consortium to focus on pediatric translational research

The Children's Hospital of Philadelphia CEO Steven M. Altschuler, Drexel University President John A. Fry, and Hebrew University of Jerusalem President Menahem Ben-Sasson signed a research agreement on November 11 as part of Philadelphia Mayor Michael A. Nutter's trade mission to Israel. The research partnership is designed to focus on pediatric translational research and to develop a collaborative platform for advancing pediatric medicine from the lab to the bedside.

13 Nov 2013

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Global health advocates today commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. Pneumonia took the lives of nearly 1.1 million children under 5 in 2012 alone, with more than 99 percent of these deaths in developing countries, where access to healthcare facilities and treatment is out of reach for many children.

12 Nov 2013

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

Agilent Technologies Inc. has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable advanced discoveries in cancer and cytogenetics research.

12 Nov 2013

New diagnostic products from Avantor™ Performance Materials featured at MEDICA 2013

Avantor™ Performance Materials will display its capabilities as a trusted collaborator and provider of high-quality diagnostic solutions at MEDICA 2013, November 20-23 at the Dusseldorf Fairgrounds in Germany.

12 Nov 2013

Leica Biosystems launches new Novocastra HD menu for hematopathology

Leica Biosystems announces the launch of the fourth Novocastra HD menu, focused on hematopathology. Previously launched were the Novocastra HD menus for breast, head & neck and dermatopathology.

12 Nov 2013

INTEGRA launches new PIPETBOY acu 2 serological pipettor

Building upon over 30 years of unmatched quality and hundreds of thousands of instruments in use worldwide - INTEGRA announces the launch of the new PIPETBOY acu 2 serological pipettor.

From INTEGRA Biosciences 11 Nov 2013

ERBA Diagnostics’ net revenues increase 83% to $6,941,000 in third quarter 2013

ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, reported its financial results for the three and nine months ended September 30, 2013.

11 Nov 2013

ReShape Duo Intragastric Balloon treatment for weight loss meets primary efficacy endpoints

ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.

11 Nov 2013

Four-year study to develop targeted approach to psoriasis treatment

A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's individual biological make-up.

8 Nov 2013

Hologic's Aptima HPV 16 18/45 genotype assay gets FDA approval for use on Panther system

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration has approved the Aptima HPV 16 18/45 genotype assay for use on the Company's fully automated Panther system.

From Hologic, Inc. 8 Nov 2013

Diagnostics News and Research

Genome sequence data indicates that common species of malaria may evolve to become bigger threat

Collaborative initiative set up to create precision medicine treatment pathways for advanced cancers

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

Pancreatic Cancer Action Network teams up with Royal Pains cast to educate on pancreatic cancer

New Malaria Vaccine Technology Roadmap aims to identify second generation malaria vaccines

Identifying 'sensome' of microglia could improve treatments for neurodegenerative disorders

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

High-power blue laser gadgets can cause serious eye damage

AMP 2013: EKF Molecular Diagnostics to launch four new PointMan DNA enrichment kits

immatics, Roche enter into cancer vaccine and immunotherapy deal

International research consortium to focus on pediatric translational research

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

New diagnostic products from Avantor™ Performance Materials featured at MEDICA 2013

Leica Biosystems launches new Novocastra HD menu for hematopathology

INTEGRA launches new PIPETBOY acu 2 serological pipettor

ERBA Diagnostics’ net revenues increase 83% to $6,941,000 in third quarter 2013

ReShape Duo Intragastric Balloon treatment for weight loss meets primary efficacy endpoints

Four-year study to develop targeted approach to psoriasis treatment

Hologic's Aptima HPV 16 18/45 genotype assay gets FDA approval for use on Panther system

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News